Center-Authored Papers

Filters: Author is Winship, Ingrid M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
F
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW et al..  2015.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.. JAMA. 314(1):61-71. Abstract
G
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
L
Antill YC, Dowty JG, Win AK, Thompson T, Walsh MD, Cummings MC, Gallinger S, Lindor NM, Le Marchand L, Hopper JL et al..  2015.  Lynch Syndrome and Cervical Cancer.. International journal of cancer. Journal international du cancer. 137(11):2757-61. Abstract
M
Chau R, Dashti SG, Ouakrim DA, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA et al..  2016.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.. International journal of epidemiology. 45(3):940-953. Abstract
R
Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti GS, Ouakrim DA, Winship IM, Macrae FA, Boussioutas A, Giles GG et al..  2016.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.. International journal of cancer. Abstract
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
Win AK, Reece JC, Buchanan DD, Clendenning M, Young JP, Cleary SP, Kim H, Cotterchio M, Dowty JG, MacInnis RJ et al..  2015.  Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.. Familial cancer. 14(4):575-83. Abstract
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H et al..  2016.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.. International journal of cancer. 139(7):1557-1563. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract